Abstract
Personalized dosimetry with high accuracy is crucial owing to the growing interests in personalized medicine. The direct Monte Carlo simulation is considered as a state-of-art voxel-based dosimetry technique; however, it incurs an excessive computational cost and time. To overcome the limitations of the direct Monte Carlo approach, we propose using a deep convolutional neural network (CNN) for the voxel dose prediction. PET and CT image patches were used as inputs for the CNN with the given ground truth from direct Monte Carlo. The predicted voxel dose rate maps from the CNN were compared with the ground truth and dose rate maps generated voxel S-value (VSV) kernel convolution method, which is one of the common voxel-based dosimetry techniques. The CNN-based dose rate map agreed well with the ground truth with voxel dose rate errors of 2.54% ± 2.09%. The VSV kernel approach showed a voxel error of 9.97% ± 1.79%. In the whole-body dosimetry study, the average organ absorbed dose errors were 1.07%, 9.43%, and 34.22% for the CNN, VSV, and OLINDA/EXM dosimetry software, respectively. The proposed CNN-based dosimetry method showed improvements compared to the conventional dosimetry approaches and showed results comparable with that of the direct Monte Carlo simulation with significantly lower calculation time.
Subject terms: Positron-emission tomography, Biomedical engineering
Introduction
Internal dosimetry is becoming increasingly important owing to the growing interest in targeted radionuclide therapies, radiotheranostics, and personalized medicine1–3. Conventionally, internal dosimetry is conducted using the schema provided by the Medical Internal Radiation Dose (MIRD) committee of the Society of Nuclear Medicine4–6. Thus far, organ-based dosimetry is considered as a practical approach to internal dosimetry in nuclear medicine. The organ-based dosimetry calculates organ doses by applying organ-level S-values, which represent the absorbed doses to a target organ per unit activity in a source organ, on the generalized human mathematical phantom. However, organ-based MIRD schema assumes uniform activity distribution in each organ, which is not true. Furthermore, patient-specific body anatomy and tissue composition are not considered.
Therefore, voxel-based dosimetry techniques that consider heterogeneous activity distributions have been suggested, including the dose point kernel7–9 and voxel S-value (VSV) approaches10. The dose point kernel represents a radial absorbed dose in a homogeneous water medium when an isotropic point source is located at the center11–15. The VSV is the voxel-level MIRD schema, in which sources and targets are defined in the voxel-level, and the voxel S-values are calculated in a 3D voxel matrix composed of the water medium. However, the application of the DPK or VSV methods is limited to lesions in homogeneous tissue media (i.e. hepatic 90Y-microsphere therapy) because the medium heterogeneity is not considered in these relatively simple analytical approaches.
For more accurate personalized dosimetry, voxel-based dosimetry based on direct Monte Carlo simulation that can consider both heterogeneous activities and medium distributions has been suggested. The Monte Carlo simulation generates and tracks particles at the voxel-level and calculates deposited energy to estimate the voxel-level absorbed doses16,17. Nevertheless, this approach requires extensive computational time and resources; hence, it is rarely used in a clinical routine basis. Therefore, it is necessary to develop a fast voxel-based dosimetry technique that takes accounts of heterogeneous activities and medium distribution.
Recently, deep neural networks, which is well-known as deep learning, has gained huge attention in various fields18,19. In particular, deep learning approaches outperforms conventional image processing approaches in many different tasks including image classifications, segmentations, and generations20–27. Furthermore, there have been some recent attempts to use deep learning techniques for radiation dose estimation28–30. However, these deep learning applications are only limited to external radiation therapy.
In this study, we suggest a new internal radiation dose calculation method, called Deep-dose, which applies a convolutional neural network (CNN) to estimate the voxel dose values from the individual nuclear medicine images. The absolute 3D radioactivity distribution given by quantitative positron emission tomography (PET) or single photon emission tomography (SPECT) and media property derived from transmission scans, such as X-ray computed tomography (CT), are fed to the CNN as an input, and the CNN is then trained to generate the dose rate map as an output, with the Monte Carlo simulation based dose rate map as the reference (ground truth). We adopted 3D patch-based network training rather than image-to-image mapping as shown in Fig. 1, considering the range of dose delivery from a source voxel to surrounding tissues. To show the feasibility of the Deep-dose method, we applied it to the PET/CT data set of 68Ga-NOTA-RGD, which is a promising diagnostic PET agent for angiogenesis assessment. We evaluated the performance of the Deep-dose by comparing its results to those of direct Monte Carlo based voxel dose estimation.
Methods
Patient data set
In this study, patient datasets (10 subjects; four females and six males; 53.7 ± 13.5 years; 61.5 ± 7.4 kg) acquired in our previous study were used retrospectively31. All procedures in this study were approved by the Institutional Review Board of Seoul National University Hospital, Seoul, Korea and performed in accordance with relevant guidelines and regulations. The retrospective use of the scan data and waiver of consent were approved by the Institutional Review Board of our institute. Dynamic PET/CT images at eight time points were acquired after an intravenous injection of 68Ga-NOTA-RGD. The durations of emission scans varied from 30 to 300 seconds per bed, and the scans were started at 1, 4, 7, 10, 15, 30, 46, and 62 min post-injection. The detailed PET/CT imaging protocol is described by Kim et al.31. The reconstructed PET images had dimensions of 256 × 256 × 165 with a voxel size of 2.67 × 2.67 × 5 mm3. The regions-of-interests were manually drawn on the CT images for eight organs: gallbladder wall, heart, kidneys, liver, lungs, pancreas, spleen, and stomach wall. All region-of-interests were drawn by a single individual (nuclear medicine physicist) and confirmed with other nuclear medicine physicists.
Dose estimation using direct Monte Carlo simulation
Dose estimation using the direct Monte Carlo simulation was considered as the ground truth data. The Geant4 Application for Emission Tomography (GATE) v.7.0 simulation toolkit32,33 was used to generate the ground truth dose maps. The patient PET and CT images were imported to simulate the voxelized source distribution and voxelized phantom. The CT images were matched with the PET images to have the same matrix and pixel sizes. CT Hounsfield units were converted into densities based on the published database34. The standard electromagnetic physics package of Geant4 v.9.6.3 was used for simulating the 68Ga ion particles and photon interactions at each voxel with specific material composition. The dose calculation mechanism called “Dose Actor” was used for voxel dose calculation33. An in-house computing cluster with a 60-cores of Intel XEON 2.4 GHz CPU and 80 GB DDR3 RAM was used for the simulation. Owing to the long simulation time and extensive computational cost for the Monte Carlo simulation, the simulation was conducted only for 5% of the real scan duration of each PET frame. Although the simulation was performed only for 5% of actual events, the statistical uncertainties of the dose estimation at the voxel-level was less than 0.1% for all voxels. The generated 3D dose maps (Gy = J/kg) from the GATE simulation were divided using the corresponding simulation times to generate the 3D dose rate maps (Gy/s) and used as reference data for the CNN.
Dose estimation using voxel S-value kernel convolution
For the comparison, we used the VSV kernel convolution method to calculate voxel doses. The VSV (Gy/MBq·s) was generated using the previously described GATE simulation set up while placing the 68Ga point source at the center of the water medium. The VSV kernel had the same voxel size as the PET image. The time-integrated activity () (MBq·s) was convoluted with the VSV kernel to generate the voxel dose () (Gy) as shown by the equation below.
Voxel dose estimation using deep convolutional neural network
Network architecture
The deep neural network used for the voxel dose estimation is based on U-net structure25 that has a large receptive field and shown remarkable performance in various image processing tasks including image segmentation, restoration, and denoising23,35. Because the dose of a voxel is determined by the surrounding source and the medium distributions, we performed 3D patch-based training of U-net (Fig. 1). We designed the network to predict the dose rate map using the PET and CT image patches as inputs after training the network using the Monte Carlo simulation-based ground truth dose rate map as a reference. Each image patch had a matrix size of 48 × 48 × 24. We determined the matrix size to be large enough to cover the dose range of 68Ga to avoid the underestimation of the absorbed dose36.
Figure 1 shows the U-net network architecture24, consisting of a contracting and expanding path. The contracting path consists of the 3 × 3 × 3 convolution layer each followed by batch normalization, rectified linear units as an activation function, and a 2 × 2 × 2 max pooling layer. The expansion path consisted of 3 × 3 × 3 convolution and deconvolution, each followed by rectified linear units and recovered feature maps into high-resolution images by copying and concatenating the feature maps from the contracting path. The number of feature maps in the first layer was empirically set to 14, then doubled in the contracting path, and finally reduced by half in the expanding path.
Network training and testing
The network was trained and tested by the fashion of five-fold cross-validation. In each cross-validation, eight out of the ten patient datasets were used for network training and the remaining two datasets were used to test the performance of the proposed CNN approach. Therefore, all patient datasets were used for network training four times and exactly once for testing.
To increase the number of training data, one static PET/CT image set with a matrix size of 256 × 256 × 165 was divided into 3D image patches with a matrix size of 48 × 48×24 (patch-based learning). In order to keep the dose contribution from the outside of the given image patch, image patches were generated with overlaps with 7 pixel offsets in the transverse direction and 5 pixel offsets in the axial direction. Total 5,000 image patches were generated from a single static image, while image patches which contained less than a one eights of the imaged body part were excluded. Therefore, the total number of training dataset were 8 (number of patients) × 8 (number of time points) × 5,000 (number of image patches) = 320,000 each for PET and CT inputs.
The cost function was L1-norm between the ground truth dose rate map and the dose rate map predicted by the CNN. The cost function was minimized using the adaptive moment (ADAM) estimation method. The batch size for batch normalization was 150 and the number of epochs was seven. The network was implemented using TensorFlow under the computational environment with Intel Core i5-2500 CPU and GTX 1080 Ti GPU.
The dose rate maps generated using the trained CNN were compared to the ground truth dose rate map obtained using direct Monte Carlo simulation. The dose rate maps estimated by the VSV kernel convolution method were also compared. Errors at the voxel-level were analyzed in terms of relative and absolute differences and represented in the 3D difference map. Mean voxel-level dose difference at eight different organs were reported by calculating the mean value of absolute dose % differences in each organ. Also, we conducted paired t-test between voxel-level dose rates of the ground truth and VSV- and CNN-based dose estimation, respectively. Bonferroni correction was applied to adjust levels of significance for multiple t-tests. The test rejected the null hypothesis at the 5% significance level.
Finally, whole-body dosimetry was conducted using the proposed CNN-based approach, VSV kernel convolution, and organ-based dosimetry approach using OLINDA/EXM software6. The outcome of these three different approaches were compared with the ground truth. The dose rate maps at each time point were integrated by the trapezoidal sum of dose rate until the last time point (62 min) and extrapolation of the tail to the infinity to acquire absorbed doses. Absorbed doses for each organ were corrected using the organ masses of the Oak Ridge National Laboratory stylized phantoms for the fair comparison with the organ-based dosimetry results published by Kim et al.31. Paired t-test was conducted between absorbed organ doses of the ground truth and VSV-, CNN-, and MIRD-based absorbed dose, respectively.
Results
Whole-body dose rate maps
The whole-body dose rate maps generated by direct Monte Carlo simulation, which is considered as the ground truth, were compared with conventional VSV kernel convolution and the proposed approach. As shown in Fig. 2, the proposed CNN approach yielded dose rate maps that agreed well with the ground truth. Moreover, the CNN approach showed remarkably better results in lungs compared to the VSV kernel method (red arrows in Fig. 2).
Figure 3 shows the dose rate profile of each method along the coronal and axial slices. The VSV approach showed a similar profile with the direct Monte Carlo simulations on the soft tissue regions (heart, liver, and kidneys) while significant underestimation of dose for the lungs was observed owing to the medium density mismatch in the VSV kernel. However, the results of the proposed approach matched very well with the direct Monte Carlo approach for all regions regardless of the medium density.
Voxel-level dose rate error
To analyze the dosimetric accuracy quantitatively, we calculated errors at the voxel-level and generated 3D maps of relative and absolute differences of the dose rate. Figure 4 shows four coronal slices of a representative case. The VSV kernel convolution approach yielded low errors in the soft tissue regions while those of the lungs, bone, and air cavity regions had high errors due to the VSV density mismatch as shown in Fig. 4(a,c). The CNN approach showed low and uniform errors in both the relative and absolute difference map as shown in Fig. 4(b,d).
Figure 5 and Table 1 summarizes the voxel-level dose rate errors for the VSV and CNN approach for eight organs and the whole-body. The VSV kernel approach showed low voxel-level errors except for the lung with an average voxel error was 9.97% ± 1.79% at the whole-body level. However, based on the t-test results, we observed half of the organs showed significant difference with the direct Monte Carlo results. On the other hand, the CNN approach showed reliable dose rate prediction. Eight organs showed very low voxel-level errors and most of the organs except for lung showed non-significant difference with the direct Monte Carlo approach. With the CNN approach, voxel dose rate percentage errors of 2.54% ± 2.09% was achieved at the whole-body level.
Table 1.
Method | VSV | Deep-dose |
---|---|---|
Mean ± Std (%) | Mean ± Std (%) | |
Gallbladder wall | 1.38 ± 1.37 | 2.13 ± 1.70 |
NS | NS | |
Heart wall | 5.83 ± 2.16 | 1.88 ± 1.27 |
p < 0.005 | NS | |
Kidney | 1.44 ± 1.14 | 0.86 ± 0.67 |
NS | NS | |
Liver | 1.13 ± 0.68 | 1.10 ± 0.67 |
NS | NS | |
Lung | 57.09 ± 2.07 | 1.41 ± 1.29 |
p < 0.001 | p < 0.05 | |
Pancreas | 1.05 ± 0.98 | 1.47 ± 1.21 |
NS | NS | |
Spleen | 0.94 ± 0.68 | 0.85 ± 0.61 |
p < 0.01 | NS | |
Stomach wall | 4.01 ± 2.02 | 2.01 ± 1.61 |
p < 0.05 | NS | |
Whole-body (avg) | 9.97 ± 1.79 | 2.54 ± 2.09 |
The degree of significance is reported in the below of the corresponding differences (NS = nonsignificant).
*Method: VSV or Deep-dose (CNN). §DMC: direct Monte Carlo simulation.
Computation time
Training the CNN took approximately 18 hr for each epoch, and a total 126 hr for training 7 epochs. Using the trained CNN network, single dose rate maps can be generated in just 3.6 min with PET and CT input images. On the contrary, the direct Monte Carlo simulation took 235.2 hr for generating single dose rate map using a CPU with four cores and 16 GB RAM. Using the proposed CNN-based voxel dose rate estimation, we could reduce the computation time for 3D dose rate map generation. Table 2 summarizes the computation time for the single 3D dose rate map generation. However, we would like to note that the direct Monte Carlo simulation and CNN network was implemented in the different computation environment, and there is some room for speeding up the direct Monte Carlo simulation by implementing GPU-based Monte Carlo. However, the CNN-based voxel-dose calculation is still significantly faster than the direct Monte Carlo.
Table 2.
Method | Time consumption (hr) | Relative time consumption |
---|---|---|
Direct Monte Carlo (5% of actual events) | 235.20 | 1 |
Direct Monte Carlo (complete simulation) | 4704.03 | 20 |
VSV | 0.17 | 0.00074 |
Deep-dose (CNN) | 0.06 | 0.00026 |
Whole-body dosimetry in patients
Finally, the dosimetry study was conducted using the dynamic PET/CT images of 10 patients. Figure 6 and Table 3 shows the result of the whole-body dosimetry study. Our proposed method yielded better results than the conventional VSV kernel convolution and organ-based dosimetry. For the proposed CNN approach, errors at the organ level were observed under 1.5%, while VSV approach showed slightly larger organ level errors except for the lung, which showed significantly larger errors. Organ-based MIRD approach showed very large errors compared to voxel-based ground truth data. The average organ dose percentage difference was 1.07%, 9.43%, and 34.22% for the CNN, VSV, and organ-based dosimetry results, respectively. Based on the paired t-test results between the direct Monte Carlo and three different dose calculation approaches, respectively, the CNN approach showed non-significant differences in absorbed dose estimation while VSV and organ-based dosimetry approach showed significant difference in most of the organs.
Table 3.
Method | VSV | Deep-dose | Organ-based dosimetry |
---|---|---|---|
Gallbladder wall | 1.12 ± 1.17 | 1.18 ± 1.20 | 22.27 ± 22.28 |
NS | NS | p < 0.001 | |
Heart wall | 2.60 ± 1.15 | 1.14 ± 1.09 | 76.39 ± 27.05 |
p < 0.05 | NS | p < 0.001 | |
Kidney | 2.55 ± 1.14 | 0.67 ± 0.57 | 3.86 ± 3.29 |
p < 0.05 | NS | p < 0.001 | |
Liver | 1.86 ± 0.71 | 1.04 ± 0.99 | 19.01 ± 31.90 |
p < 0.01 | NS | p < 0.001 | |
Lung | 53.66 ± 3.45 | 1.30 ± 1.15 | 23.43 ± 33.86 |
p < 0.001 | NS | p < 0.001 | |
Pancreas | 1.71 ± 1.09 | 1.26 ± 1.74 | 1365.72 ± 1186.49 |
NS | NS | p < 0.001 | |
Spleen | 1.55 ± 0.97 | 0.79 ± 0.77 | 46.62 ± 104.20 |
NS | NS | p < 0.001 | |
Stomach wall | 2.70 ± 1.38 | 1.35 ± 1.19 | 42.94 ± 71.27 |
p < 0.05 | NS | p < 0.001 | |
Avg. | 8.47 ± 1.38 | 1.09 ± 1.09 | 200.66 ± 185.04 |
Avg. (excluding Pancreas) | 9.43 ± 0.85 | 1.07 ± 0.22 | 34.22 ± 31.63 |
*Method: VSV or Deep-dose (CNN). §DMC: direct Monte Carlo simulation.
The degree of significance is reported in the below of the corresponding differences (NS = nonsignificant).
Discussion
Whole-body voxel-based dosimetry techniques that use real patient anatomy and activity distributions have several advantages over conventional organ-based dosimetry. By accounting real patient information, more accurate dose information can be calculated for an individual, which is very important in personalized medicine for the risk-benefit assessments. Moreover, the 3D voxel dose distribution given by voxel-based dosimetry enables the assessment of dose volume histogram in targets. However, the current voxel-based dosimetry approaches have a limitation of dose calculation time, so rarely used in clinical practice. Therefore, fast whole-body voxel-based dosimetry technique will play a role as a powerful dosimetry toolkit and truly introduce personalized medicine in clinical routines.
In this study we used deep learning to generate the dose rate map from PET and CT images. We used deep learning as a mean of exploring the relationship between heterogeneous activity/media distributions and the deposited energies at each corresponding voxel. We used the 3D image patch-based learning for the data augmentation and the size of image patch was determined as the size of the dose kernel of a voxel S-value to avoid underestimation of energy deposition by including a sufficient energy deposition range.
Based on our result of CNN-based voxel dose estimation, we conclude that the proposed method is a promising method for voxel-based dosimetry. The difference between CNN-based dose rate map and the ground truth image was relatively small. When compared to the conventional VSV kernel convolution, the CNN outperformed on voxel dose rate estimation especially in the lungs, bones, air cavity, and in the organ boundaries as shown in Fig. 3 and Table 1. For most of the body parts, we did not observe any dose estimation bias in the image patch-based CNN approach except for the bladder, which contains ultra-high activities that leads to image artifacts in the PET image itself, we observed dose estimation bias. However, it is hard to say that this bias is caused by the CNN, because it was observed in the VSV approach as well. Finally, whole-body dosimetry study was conducted and the results of the dosimetry study (Table 3) showed that the CNN-based approach exhibited only small errors in organ dose calculation while the VSV approach exhibited large underestimation in the lung regions. The organ-based dosimetry approach showed even larger differences throughout the organs because this method is not appropriate for personalized dosimetry. Moreover, in terms of computation time, the CNN approach showed significant improvement in the time required for dose rate map generation compared to the direct Monte Carlo based voxel dose estimation as shown in Table 2.
The main limitation of this study is the small patient population (10 patients). Because our data augmentation strategy relied on the patch-based training and the use of eight time points, the data from multiple time points would be correlated thus limiting the additional information fed to the CNN. Although we tried to reduce the data correlation due to multiple data samples from the same individual by random data shuffling, validation of our proposed method with the large independent dataset is ultimately necessary. We warrant further validation studies with much larger population data and various radiotracers in the future.
Moreover, to implement our proposed method to PET or SPECT images that are acquired with other radioisotopes, additional network training is required because different isotopes have different emissions schemes with different energy values. In the proposed CNN architecture, the labeled image is required because supervised learning is used and hence the direct Monte Carlo based dose map generation is also required. Given that this ground truth dose map generation takes significantly long time, further study is required to figure out alternative methods, such as to use the labeled dose map that is generated by multiple VSV kernels37, which is much faster than Monte Carlo simulation. With the trained network, the CNN-based voxel dose map generation would be a powerful tool for the personalized dosimetry technique that realizes personalized medicine just in a few minutes. It is a bit early to say that the CNN-based approach can substitute the sophisticated nature of Monte Carlo engine; however, our result reports that CNN can be considered as a candidate for a fast voxel-based dosimetry technique.
Acknowledgements
This work was supported by grants from National Research Foundation of Korea (NRF) funded by the Korean Ministry of Science, ICT and Future Planning (Grant No. NRF-2014M3C7034000 and NRF-2016R1A2B3014645.
Author Contributions
M.S.L., D.H. and J.S.L. designed and developed the deep learning network and software framework. J.H.K. collected and provided data on organ-based dosimetry results. M.S.L. did quantitative analysis and M.S.L., D.H. and J.S.L wrote the manuscript. All authors reviewed the manuscript.
Competing Interests
The authors declare no competing interests.
Footnotes
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Fahey F, et al. Targeted radionuclide therapy: proceedings of a joint workshop hosted by the National Cancer Institute and the Society of Nuclear Medicine and Molecular Imaging. J Nucl Med. 2014;55:337–348. doi: 10.2967/jnumed.113.135178. [DOI] [PubMed] [Google Scholar]
- 2.Ahn B-C. Personalized medicine based on theranostic radioiodine molecular imaging for differentiated thyroid cancer. Bio. Med Res Int. 2016;2016:1680464. doi: 10.1155/2016/1680464. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Jadvar H, Chen X, Cai W, Mahmood U. Radiotheranostics in cancer diagnosis and management. Radiology. 2018;286:388–400. doi: 10.1148/radiol.2017170346. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Berger MJ. Energy deposition in water by photons from point isotropic sources. J Nucl Med. 1968;2:17–25. [PubMed] [Google Scholar]
- 5.Loevinger, R., Budinger, T. F. & Watson, E. E. MIRD primer for absorbed dose calculations. Society of Nuclear Medicine and Molecular Imaging (1991).
- 6.Stabin MG, Sparks RB, Crowe E. OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 2005;46:1023–1027. [PubMed] [Google Scholar]
- 7.Bolch WE, Eckerman KF, Sgouros G, Thomas SR. MIRD pamphlet no. 21: a generalized schema for radiopharmaceutical dosimetry—standardization of nomenclature. J Nucl Med. 2009;50:477–484. doi: 10.2967/jnumed.108.056036. [DOI] [PubMed] [Google Scholar]
- 8.Berger MJ. Distribution of absorbed dose around point sources of electrons and beta particles in water and other media. J Nucl Med. 1971;3:5–23. [PubMed] [Google Scholar]
- 9.Seltzer SM. Electron-photon Monte Carlo calculations: the ETRAN code. Appl Radiat Isot. 1991;42:917–941. doi: 10.1016/0883-2889(91)90050-B. [DOI] [Google Scholar]
- 10.Bolch WE, et al. MIRD pamphlet no. 17: the dosimetry of nonuniform activity distributions—radionuclide S values at the voxel level. J Nucl Med. 1999;40:11S–36S. [PubMed] [Google Scholar]
- 11.Kolbert KS, et al. Implementation and evaluation of patient specific three-dimensional internal dosimetry. J Nucl Med. 1997;38:301–308. [PubMed] [Google Scholar]
- 12.Campbell AM, Bailey IH, Burton MA. Tumour dosimetry in human liver following hepatic Yttrium-90 microsphere therapy. Phys Med Biol. 2001;46:487–498. doi: 10.1088/0031-9155/46/2/315. [DOI] [PubMed] [Google Scholar]
- 13.Sgouros G, et al. Treatment planning for internal radionuclide therapy: three-dimensional dosimetry for nonuniformly distributed radionuclides. J Nucl Med. 1990;31:1884–1891. [PubMed] [Google Scholar]
- 14.Giap HB, Macey DJ, Bayouth JE, Boyer AL. Validation of a dose-point kernel convolution technique for internal dosimetry. Phys Med Biol. 1995;40:365–381. doi: 10.1088/0031-9155/40/3/003. [DOI] [PubMed] [Google Scholar]
- 15.Sgouros G, et al. Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software. J Nucl Med. 2004;45:1366–1372. [PubMed] [Google Scholar]
- 16.Furhang EE, Chui CS, Sgouros G. A Monte Carlo approach to patient-specific dosimetry. Med Phys. 1996;23:1523–1529. doi: 10.1118/1.597882. [DOI] [PubMed] [Google Scholar]
- 17.Zaidi H. Relevance of accurate Monte Carlo modeling in nuclear medical imaging. Med Phys. 1999;26:574–608. doi: 10.1118/1.598559. [DOI] [PubMed] [Google Scholar]
- 18.Bengio Y, Courville A, Vincent P. Representation learning: a review and new perspectives. IEEE Trans Pattern Anal Mach Intell. 2013;35:1798–1828. doi: 10.1109/TPAMI.2013.50. [DOI] [PubMed] [Google Scholar]
- 19.Schmidhuber J. Deep learning in neural networks: an overview. Neural Netw. 2015;61:85–117. doi: 10.1016/j.neunet.2014.09.003. [DOI] [PubMed] [Google Scholar]
- 20.Chen, H. et al. Low-dose CT denoising with convolutional neural network. IEEE 14th Int Symp Biomed Imag, 143–6 (2017).
- 21.Dong C, Loy CC, He K, Tang X. Image super-resolution using deep convolutional networks. IEEE Trans Pattern Anal. 2016;38:295–307. doi: 10.1109/TPAMI.2015.2439281. [DOI] [PubMed] [Google Scholar]
- 22.Kang SK, et al. Adaptive template generation for amyloid PET using a deep learning approach. Human Brain Map. 2018;39:3769–3778. doi: 10.1002/hbm.24210. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Park J, et al. Computed tomography super-resolution using deep convolutional neural network. Phys Med Biol. 2018;63:145011. doi: 10.1088/1361-6560/aacdd4. [DOI] [PubMed] [Google Scholar]
- 24.Hwang D, et al. Improving the accuracy of simultaneously reconstructed activity and attenuation maps using deep learning. J Nucl Med. 2018;59:1624–1629. doi: 10.2967/jnumed.117.202317. [DOI] [PubMed] [Google Scholar]
- 25.Ronneberger, O., Fischer, P. & Brox, T. U-net: convolutional networks for biomedical image segmentation. Int Conf Medical Image Computing and Computer-Assisted Intervention. 234–241 (Springer, 2015).
- 26.Yonekura A, Kawanaka H, Prasath VS, Aronow BJ, Takase H. Automatic disease stage classification of glioblastoma multiforme histopathological images using deep convolutional neural network. Biomed Eng Lett. 2018;8:321–327. doi: 10.1007/s13534-018-0077-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Mansour RF. Deep-learning-based automatic computer-aided diagnosis system for diabetic retinopathy. Biomed Eng Lett. 2018;8:41–57. doi: 10.1007/s13534-017-0047-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Nguyen D, et al. Dose Prediction with U-net: a feasibility study for predicting dose distributions from contours using deep learning on prostate IMRT patients. arXiv preprint arXiv. 2017;1709:09233. [Google Scholar]
- 29.Kearney V, Chan JW, Haaf S, Descovich M, Solberg TD. DoseNet: a volumetric dose prediction algorithm using 3D fully-convolutional neural networks. Phys Med Biol. 2018;63:235022. doi: 10.1088/1361-6560/aaef74. [DOI] [PubMed] [Google Scholar]
- 30.Kalantzis G, Vasquez‐Quino LA, Zalman T, Pratx G, Lei Y. Toward IMRT 2D dose modeling using artificial neural networks: a feasibility study. Med Phys. 2011;38:5807–5817. doi: 10.1118/1.3639998. [DOI] [PubMed] [Google Scholar]
- 31.Kim JH, et al. Whole-body distribution and radiation dosimetry of 68Ga-NOTA-RGD, a positron emission tomography agent for angiogenesis imaging. Cancer Biother Radiopharm. 2012;27:65–71. doi: 10.1089/cbr.2011.1061. [DOI] [PubMed] [Google Scholar]
- 32.Jan S, et al. GATE: a simulation toolkit for PET and SPECT. Phys Med Biol. 2004;49:4543–4561. doi: 10.1088/0031-9155/49/19/007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Sarrut D, et al. A review of the use and potential of the GATE Monte Carlo simulation code for radiation therapy and dosimetry applications. Med Phys. 2014;41:064301. doi: 10.1118/1.4871617. [DOI] [PubMed] [Google Scholar]
- 34.Schneider W, Bortfeld T, Schlegel W. Correlation between CT numbers and tissue parameters needed for Monte Carlo simulations of clinical dose distributions. Phys Med Biol. 2000;45:459–478. doi: 10.1088/0031-9155/45/2/314. [DOI] [PubMed] [Google Scholar]
- 35.Hwang, D. et al. Generation of PET attenuation map for whole-body time-of-flight 18F-FDG PET/MRI using a deep neural network trained with simultaneously reconstructed activity and attenuation maps. J Nucl Med. 2018. In press. [DOI] [PMC free article] [PubMed]
- 36.Papadimitroulas P, Loudos G, Nikiforidis GC, Kagadis GC. A dose point kernel database using GATE Monte Carlo simulation toolkit for nuclear medicine applications: Comparison with other Monte Carlo codes. Med Phys. 2012;39:5238–5247. doi: 10.1118/1.4737096. [DOI] [PubMed] [Google Scholar]
- 37.Lee MS, et al. Whole-body voxel-based personalized dosimetry: the multiple voxel S-value approach for heterogeneous media with nonuniform activity distributions. J Nucl Med. 2018;59:1133–1139. doi: 10.2967/jnumed.117.201095. [DOI] [PubMed] [Google Scholar]